TIDMCHT

RNS Number : 4962V

Constellation Healthcare Tech, Inc

30 January 2017

30 January 2017

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

RECOMMENDED ACQUISITION

of

Constellation Healthcare Technologies, Inc. (the "Company")

by a subsidiary of CHT Holdco, LLC

to be effected by means of a merger under the laws of the State of Delaware (the "Acquisition")

Closing of Acquisition

Further to the announcement by Constellation Healthcare Technologies, Inc of the result of its General Meeting on 18 January 2017, the Company announces that the Acquisition has now closed.

Cancellation of admission of the Common Shares to trading on AIM will be effective at 7.00 a.m. (London time) on 31 January 2017 and the Receiving Agent will commence payment of the Acquisition Price to Shareholders on the same day.

To the extent that Shareholders have yet to complete and return the Form of Declarations and the Delaware Voting Agreement in accordance with the instructions set out in the Proxy Statement under the heading "Action to be Taken" they are strongly encouraged to do so by no later than 6 February 2017. Failure to return a properly completed Form of Declarations will result in the Shareholder not being able to receive either the A Promissory Notes or the B Promissory Notes. Furthermore, failure to return a properly completed Delaware Voting Agreement will result in the Shareholder not being able to receive A Promissory Notes which may have a higher value than the B Promissory Notes. The register for the Promissory Notes will close at 6.00 p.m. (London time) on 6 February 2017.

Unless otherwise provided, capitalised terms used but not otherwise defined in this announcement shall have the meanings set out in the Proxy Statement published by the Company on 28 December 2016.

Enquiries:

CC Capital Management, LLC

   Doug Newton                                                                 newton@cc.capital

Finsbury - PR adviser to CC Capital

   Charles O'Brien  (UK)                                                     Tel: +44 20 7251 3801

charles.obrien@finsbury.com

   Kal Goldberg (US)                                                          Tel: +1 646 805 2005

kal.goldberg@finsbury.com

   Chris Ryall (U.S.)                                                           Tel: +1 646 805 2078

chris.ryall@finsbury.com

Constellation Healthcare Technologies, Inc.

   Paul Parmar, Chief Executive Officer                                c/o Redleaf Communications 
   Sotirios ("Sam") Zaharis, Chief Financial Officer               Tel: +44 20 7382 4730

finnCap Ltd Tel: +44 20 7220 0500

   Stuart Andrews / Julian Blunt / Scott Mathieson               Corporate Finance 
   Simon Johnson                                                              Corporate Broking 
   Redleaf Communications - PR adviser to CHT                   Tel: +44 20 7382 4730 
   Charlie Geller / Sam Modlin                                            constellation@redleafpr.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACQEASFEDEKXEFF

(END) Dow Jones Newswires

January 30, 2017 10:07 ET (15:07 GMT)

Constellation Healthcare (LSE:CHT)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Constellation Healthcare
Constellation Healthcare (LSE:CHT)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Constellation Healthcare